Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afamelanotide as Adjunctive Therapy in PDT with Porfimer Sodium
NCT04425746Phase 2Completed
- Sponsor
- Clinuvel Pharmaceuticals
- Start
- Aug 2008
- Primary completion
- May 2009
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of Afamelanotide in Phototoxicity, sponsored by Clinuvel Pharmaceuticals. Started Aug 2008; status: completed.
02
Drugs
Afamelanotide
03
Conditions
Phototoxicity
Beyond the preview
Go deeper on NCT04425746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04425746.